Home > Learning > APS > Clinical

Module 2 of 3 • 5 min • Clinical Manifestations

When Accounts Get Frozen

“The Six Clinical Domains”

The fraud detection system has gone rogue. You identified the culprits in Module 1 — the three departments falsely flagging legitimate transactions. But here’s the problem: you didn’t catch them in time. They’ve already started freezing accounts across the bank.

And depending on which branch they hit, the consequences look very different. A frozen checking account is inconvenient. A frozen investment account is devastating. A system-wide crash is catastrophic. The 2023 ACR/EULAR criteria organize these consequences into six clinical domains — six different ways the bank gets hit.

Key Question

What are the six clinical domains of APS, what does each look like, and how do you put the clinical + lab pieces together for classification?

The Six Domains

1

Checking Accounts — Macrovascular Venous (VTE)

The most common manifestation. Everyday accounts frozen first.

The most everyday accounts — checking. These handle routine daily transactions. When checking accounts freeze, it’s the most common and most recognizable problem: DVT and PE.

  • DVT of lower extremities = single most common thrombotic event in APS
  • Unusual-site venous thrombosis (cerebral venous sinus, Budd-Chiari, renal vein) carries higher weight — more specific for APS
  • Unprovoked VTE in a young patient (<50, especially women) should always trigger aPL testing
2023 Scoring: Provoked DVT/PE = 1pt  |  Unprovoked DVT/PE = 3pts  |  Unusual-site venous = 3pts
2

Investment Accounts — Macrovascular Arterial

Less common than venous, but the stakes are much higher.

Now the rogue system targets the high-value accounts — investments, retirement funds. When these get frozen, the consequences are catastrophic: stroke and MI in young patients.

  • Stroke is the most common arterial event, especially in patients <50 without CV risk factors
  • MI in APS is typically from in situ thrombosis, not atherosclerotic plaque rupture
  • Peripheral and renal arterial thrombosis also occur
2023 Scoring: With CV risk factors = 2pts  |  Without CV risk factors = 4pts
Board Pearl

Young stroke (<50) + no cardiovascular risk factors = always test for aPL. This is one of the highest-yield setups on boards.

3

Small Branch Network — Microvascular Disease

NEW in 2023 — the distributed network goes down quietly.

Beyond the big accounts, there’s the small branch network — thousands of tiny, distributed transactions running in parallel. When this goes down, you don’t get one dramatic freeze; you get widespread, subtle dysfunction across many small systems simultaneously.

  • NEW in 2023 — not part of old Sapporo criteria
  • APS nephropathy: thrombotic microangiopathy (NOT lupus nephritis — look for TMA on biopsy)
  • Livedo reticularis: net-like mottled skin = microvascular dysfunction
  • Livedoid vasculopathy, adrenal hemorrhage
2023 Scoring: Livedo reticularis = 2pts  |  Biopsy-proven TMA/livedoid vasculopathy = 5pts  |  Adrenal hemorrhage = 5pts
4

Construction Project Funding — Obstetric APS

The critical supply line to the project gets cut.

Pregnancy is a major new construction project that requires a constant flow of funds (blood through the placenta). When the fraud system blocks that supply line, the project stalls or fails.

  • ≥3 consecutive early losses (<10 wk) after excluding other causes = 1pt
  • Fetal loss ≥10 wk = 3pts (major supply blocked mid-project)
  • Severe preeclampsia/eclampsia <34 wk = 4pts (emergency shutdown)
  • Obstetric APS can exist WITHOUT thrombosis — some patients only ever have pregnancy complications
Board Pearl

Purely obstetric APS patients often do NOT meet 2023 classification criteria (designed for research specificity). Classification criteria ≠ diagnostic criteria.

5

Valve Gates — Cardiac Valve Disease

New to scored domains in 2023. The gates start to malfunction.

The bank’s valve gates — they’re supposed to open and close smoothly, controlling flow between chambers. When the fraud system targets them, they malfunction: Libman-Sacks endocarditis, sterile vegetations on the mitral and aortic valves.

  • Valve thickening/regurgitation on echo = 2pts
  • Typically mitral and aortic valves
  • Can be a source of embolic stroke
  • Distinguish from infective endocarditis (blood cultures negative, vegetations usually smaller)
6

Friendly Fire — Hematologic Manifestations

The fraud system starts targeting the bank’s own employees.

In the chaos, the bank’s own staff get caught in the crossfire. The most common casualty: thrombocytopenia — platelets consumed in the process of forming clots.

  • 20–50% of APS patients have thrombocytopenia
  • Usually moderate (50,000–100,000) — severe = consider other diagnoses
  • THE PARADOX: Low platelets but at risk for CLOTTING, not bleeding (like HIT)
  • Persistent thrombocytopenia = 2pts
“Platelets low but clots still flow — APS paradox, now you know” — Thrombocytopenia in APS means clotting risk, not bleeding risk.

Catastrophic APS — System-Wide Meltdown

The entire banking system crashes. Every branch, every ATM, every portal — frozen simultaneously. Catastrophic APS is the rarest (<1%) and deadliest (30–50% mortality) variant: widespread thrombosis affecting ≥3 organ systems developing over ≤1 week, with small vessel predominance.

Classic triggers: infection, surgery, anticoagulation withdrawal. Treatment = everything deployed at once: anticoagulation + steroids + plasma exchange ± IVIG.

2023 Classification Framework

1
Entry: At least one positive aPL test within 3 years of event
2
Score Clinical: Pick highest-weighted item per domain (D1–D6)
3
Score Lab: LA assays (1–5pts) + aCL/anti-β2GPI ELISA (1–7pts)
4
Classify: Clinical ≥3 AND Lab ≥3 = APS
“Three-and-Three to Get the Key” — ≥3 clinical AND ≥3 lab points to classify as APS.
Key Nuance

2023 criteria traded sensitivity for specificity: 99% specific but 84% sensitive (vs. old Sapporo: 86% specific, 99% sensitive). Some true APS patients won’t meet classification criteria — that’s by design.

Test Yourself

Q1: A 28-year-old woman with 3 consecutive early pregnancy losses, no thrombosis, LA positive, aCL IgG 62 GPL. Does she meet 2023 criteria?

Show Answer

Q2: A 35-year-old man with known APS on warfarin undergoes knee surgery. Anticoagulation held. Five days post-op: renal failure, stroke, and ARDS over 48 hours. Diagnosis?

Show Answer

Q3: A patient with APS has livedo reticularis, proteinuria, and rising creatinine. Biopsy shows thrombotic microangiopathy without immune complex deposition. Diagnosis and significance?

Show Answer

Summary

  • Six clinical domains: Venous, Arterial, Microvascular (NEW), Obstetric, Cardiac valve (NEW to scoring), Hematologic (NEW to scoring)
  • DVT/PE = most common manifestation; stroke = most common arterial event
  • Young stroke (<50) without risk factors = test aPL
  • Obstetric APS can exist without thrombosis
  • Classification requires ≥3 clinical AND ≥3 lab points (“Three-and-Three to Get the Key”)
  • CAPS = ≥3 organs in ≤1 week — treat with combination therapy
  • 2023 criteria: 99% specific, 84% sensitive (traded sensitivity for specificity)
← Previous: Lab InterpretationNext: Management & Treatment →